Inhibition of transforming growth factor beta1-induced hepatoma cell apoptosis by liver tumor promoters: Characterization of primary signaling events and effects on CPP32-like caspase activity

Cell Death and Differentiation

Volumn 6, Issue 2, 1999, Pages 190-200

  Buchmann, Albrecht ^a   Willy, Claudia ^a   Buenemann, Christoph Lars ^a   Stroh, Christopher ^a   Schmiechen, Alexander ^a   Schwarz, Michael ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Anti apoptotic signaling; Apoptosis; CPP32 (caspase 3) activity; Hepatoma cells; Tumor promoters

Indexed keywords

CASPASE; CHLORPHENOTANE; CLOFIBRATE; DIELDRIN; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; PHENOBARBITAL; PROTEIN BCL X; TRANSFORMING GROWTH FACTOR BETA1; TUMOR PROMOTER;

APOPTOSIS; ARTICLE; CELL SURVIVAL; ENZYME ACTIVATION; ENZYME INHIBITION; HEPATOMA CELL; LIVER TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 0033063453     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400475     Document Type: Article

References (45)

1. Pitot HC and Sirica AE (1980) The stages of initiation and promotion in hepatocarcinogenesis. Biochim. Biophys. Acta 605: 191-215
2. Schulte-Hermann R (1985) Tumor promotion in the liver. Arch. Toxicol. 57: 147-158
3. Schulte-Hermann R, Grasl-Kraupp B and Bursch W (1995) Apoptosis and hepatocarcinogenesis. In Liver Regeneration and Carcinogenesis. Jirtle R, ed. (San Diego: Academic Press) pp. 141-178
4. Schwarz M, Buchmann A, Stinchcombe S, Luebeck G, Moolgavkar S and Bock KW (1995) Role of receptors in human and rodent hepatocarcinogenesis. Mutat. Res. 333: 69-79
5. Stinchcombe S, Buchmann A, Bock KW and Schwarz M (1995) Inhibition of apoptosis during 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated tumour promotion in rat liver. Carcinogenesis 16: 1271-1275
6. Bayly AC, Roberts RA and Dive C (1994) Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator nafenopin. J. Cell. Biol. 125: 197-203
7. Chuang L-Y, Hung W-C, Chang C-C and Tsai J-H (1994) Characterization of apoptosis induced by transforming growth factor β1 in human hepatoma cells. Anticancer Res. 14: 147-152
8. Wright SC, Zhong J and Larrick JW (1994) Inhibition of apoptosis as a mechanism of tumor promotion. FASEB J. 8: 654-660
9. Wörner W and Schrenk D (1996) Influence of liver tumor promoters on apoptosis in rat hepatocytes induced by 2-acetylaminofluorene, ultraviolet light, or transforming growth factor β1. Cancer Res. 56: 1272-1278
10. Roberts RA, James NH, Woodyatt NJ, Macdonald N and Tugwood JD (1998) Evidence for the suppression of apoptosis by the peroxisome proliferator activated receptor alpha (PPARα). Carcinogenesis 19: 43-48
11. Sell C, Baserga R and Rubin R (1995) Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. Cancer Res. 55: 303-306
12. Tanaka S and Wands JR (1996) Insulin receptor substrate 1 overexpression in human hepatocellular carcinoma cells prevents transforming growth factor β1-induced apoptosis. Cancer Res. 56: 3391-3394
13. Hale AJ, Smith CA, Sutherland LC, Stoneman VEA, Longthorne VL, Culhane AC and Williams GT (1996) Apoptosis: molecular regulation of cell death. Eur. J. Biochem. 236:1-26
14. White E (1996) Life, death, and the pursuit of apoptosis. Genes Dev. 10: 1-15
15. Kroemer G (1997) The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Med. 3: 614-620
16. Reed JC (1997) Double identity for proteins of the Bcl-2 family. Nature 387: 773-776
17. XiaZ, Dickens M, Raingeaud J, Davis RJ and Greenberg ME (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331
18. Franke TF, Kaplan DR and Cantley LC (1997) P13K: Downstream AKTion blocks apoptosis. Cell 88: 435-437
19. Marte BM and Downward J (1997) PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem. Sci. 22: 355-358
20. Baichwal VR and Baeuerle PA (1997) Apoptosis: Activate NF-κB or die? Curr. Biol. 7: R94-96
21. Oltvai Z and Korsmeyer S (1994) Checkpoints of dueling dimers foil death wishes. Cell 79: 189-192
22. Alnemri ES (1997) Mammalian cell death proteases: a family of highly conserved aspartate specific cysteine proteases. J. Cell. Biochem. 64: 22-42
23. Cohen GM (1997) Caspases: the executioners of apoptosis. Biochem. J. 326: 1-16
24. Rodriguez I, Matsuura K, Ody C, Nagata S and Vassalli P (1996) Systemic injection of a tetrapeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death. J. Exp. Med. 184: 2067-2072
25. Rouquet N, Pages J-C, Molina T, Briand P and Joulin V (1996) ICE inhibitor YVADcmk is a potent therapeutic agent against in vivo liver apoptosis. Curr. Biol. 6: 1192-1195
26. 1-induced apoptosis in rat hepatocytes. Hepatology 25: 1516-1526
27. Killary AM and Fournier REK (1984) A genetic analysis of extinction: transdominant loci regulate expression of liver-specific traits in hepatoma hybrid cells. Cell 38: 523-534
28. Cox G (1995) Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. J. Immunol. 154: 4719-4725
29. Chang T-C, Hung M-W, Jiang S-Y, Chu J-T, Chu L-L and Tsai L-C (1997) Dexamethasone suppresses apoptosis in a human gastric cancer cell line through modulation of bcl-x gene expression. FEBS Lett. 415: 11-15
30. Wen L-P, Madani K, Fahrni JA, Duncan SR and Rosen GD (1997) Dexamethasone inhibits lung epithelial cell apoptosis induced by IFN-γ and Fas. Am. J. Physiol. 273: L921-929
31. Osanai M, Ogawa K and Lee G-H (1997) Phenobarbital causes apoptosis in conditionally immortalized mouse hepatocytes depending on deregulated c-myc expression: Characterization of an unexpected effect. Cancer Res. 57: 2895-2903
32. Alessenko AV, Boikov PY, Filippova GN, Khrenov AV, Loginov AS and Makarieva ED (1997) Mechanisms of cycloheximide-induced apoptosis in liver cells. FEBS Lett. 416: 113-116
33. Linger C, Buchmann A, Buenemann CL, Kress S and Schwarz M (1998) Wild-type function of the p53 tumor suppressor protein is not required for apoptosis of mouse hepatoma cells. Cell Death Differ. 5: 87-95
34. Wang H-G, Rapp UR and Reed JC (1996) Bcl-2 targets protein kinase Raf-1 to mitochondria. Cell 87: 629-638
35. L. Cell 87: 619-628
36. Datta SR, Dudek H, Tao X, Masters S, Fu H. Gotoh Y and Greenberg ME (1997) Akt phosphorylation of BAD couples survival signals to the cel-intrinsic death machinery. Cell 91: 231-241
37. Del Peso L, Gonzalez-Garcia M, Page C, Herrera R and Nunez G (1997) Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278: 687-689
38. Heldin CH, Miyazono K and ten-Dijke P (1997) TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390: 465-471
39. Kretzschmar M, Doody J and Massague J (1997) Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1. Nature 389: 618-622
40. Keller SR and Linehard GE (1994) Insulin signalling: the role of the insulin receptor substrate 1. Trends Cell. Biol. 4: 115-119
41. Arsura M, FitzGerald MJ, Fausto N and Sonenshein GE (1997) Nuclear factor-kappaB/Rel blocks transforming growth factor beta1-induced apoptosis of murine hepatocyte cell lines. Cell Growth Differ. 8: 1049-1059
42. Scheuten GJ, Vergegaal AC, Whiteside ST, Israel A, Toebes M, Dorsman JC, van-der-Eb AJ and Zantema A (1997) IkappaB alpha is a target for mitogen-activated 90 kDa ribosomal S6 kinase. EMBO J. 16: 3133-3144
43. Li Y, Leung LK, Glauert HP and Spear BT (1996a) Treatment of rats with the peroxisome proliferator cipofibrate results in increased liver NF-kappaB activity. Carcinogenesis 17: 2305-2309
44. Li Y, Leung LK, Spear BT and Glauert HP (1996b) Activation of hepatic NF-kappaB by phenobarbital in rats. Biochem. Biophys. Res. Commun. 229: 982-989
45. Pahl HL, Krauss B, Schulze-Osthoff K, Decker T, Traencker EB, Vogt M, Myeres C, Parks T, Warring P, Muhlbacher A, Czernilofsky AP and Baeuerle PA (1996) The immuno-suppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaB. J. Exp. Med. 183: 1829-1840